{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:07:52Z","timestamp":1791266872732,"version":"4.1.0"},"reference-count":228,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.neurobiolaging.2006.06.021","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T14:32:35Z","timestamp":1154529155000},"page":"1465-1480","source":"Crossref","is-referenced-by-count":120,"title":["Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?"],"prefix":"10.1016","volume":"28","author":[{"given":"Russell H.","family":"Swerdlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/geront\/35.4.526","article-title":"The Alzheimerization of aging","volume":"35","author":"Adelman","year":"1995","journal-title":"Gerontologist"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib2","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","article-title":"Effects of rofecoxib or naproxen vs. placebo on Alzheimer disease progression: a randomized controlled trial","volume":"289","author":"Aisen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib3","first-page":"146","article-title":"Uber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allg Z Psychiat Psych-Gerichtl Med"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib4","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.36.11.1497","article-title":"Origin of the distinction between Alzheimer's disease and senile dementia: how history can clarify nosology","volume":"36","author":"Amaducci","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0047-6374(01)00426-2","article-title":"Ageing of the brain","volume":"123","author":"Anderton","year":"2002","journal-title":"Mechanisms of Ageing and Development"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib6","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/01.wnr.0000137183.68847.4e","article-title":"Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition","volume":"15","author":"Arendash","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1101\/lm.43701","article-title":"Learning and memory in transgenic mice modeling Alzheimer's disease","volume":"8","author":"Ashe","year":"2001","journal-title":"Learn Mem"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1037\/0894-4105.19.4.520","article-title":"Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis","volume":"19","author":"Backman","year":"2005","journal-title":"Neuropsychology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1471-4159.2004.02731.x","article-title":"Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts","volume":"91","author":"Bellingham","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archneur.1993.00540040011008","article-title":"Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older","volume":"50","author":"Berg","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archneur.55.3.326","article-title":"Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype","volume":"55","author":"Berg","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib12","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.0550-04.2004","article-title":"Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer's disease","volume":"24","author":"Bergamaschini","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj3230577","article-title":"Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration","volume":"323","author":"Billingsley","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib14","series-title":"A placebo controlled, double-blind trial of the selective A\u03b2-lowering agent Flurizan in patients with mild to moderate Alzheimer's disease: efficacy, safety, and follow-on study results","author":"Black","year":"2005"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archneur.55.3.294","article-title":"The genetics of Alzheimer disease: current status and future prospects","volume":"55","author":"Blacker","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.114.512.797","article-title":"The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects","volume":"114","author":"Blessed","year":"1968","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archneur.62.2.185","article-title":"Mouse models of human neurodegenerative disorders: requirements for medication development","volume":"62","author":"Bloom","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-510X(98)00128-2","article-title":"History of dementia and dementia in history: an overview","volume":"158","author":"Boller","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological staging of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer's disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib21","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJM200111223452110","article-title":"Do nonsteroidal anti-inflammatory drugs reduce the risk of Alzheimer's disease?","volume":"345","author":"Breitner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1352\/0895-8017(2004)109<83:RFFDIP>2.0.CO;2","article-title":"Risk factors for dementia in people with down syndrome: issues in assessment and diagnosis","volume":"109","author":"Bush","year":"2004","journal-title":"Am J Ment Retard"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0197-4580(94)90041-8","article-title":"Preliminary evidence: decreased GAP-43 message in tangle-bearing neurons relative to adjacent tangle-free neurons in Alzheimer's disease parahippocampal gyrus","volume":"15","author":"Callahan","year":"1994","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00005072-199903000-00007","article-title":"Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles","volume":"58","author":"Callahan","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jnen\/61.5.384","article-title":"Progressive reduction of synaptophysin message in single neurons in Alzheimer's disease","volume":"61","author":"Callahan","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","article-title":"Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum","volume":"65","author":"Campion","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1126\/science.1058783","article-title":"A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60","volume":"293","author":"Cao","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib28","doi-asserted-by":"crossref","first-page":"24601","DOI":"10.1074\/jbc.M402248200","article-title":"Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation","volume":"279","author":"Cao","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib29","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1093\/brain\/awh296","article-title":"Six month recovery from mild to moderate traumatic brain injury: the role of APOE-epsilon 4 allele","volume":"127","author":"Chamelian","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib30","series-title":"Almond diet improves hippocampal-based behavior in TgCRND8","author":"Chauhan","year":"2005"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1196\/annals.1332.005","article-title":"NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models","volume":"1035","author":"Cole","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neurobiolaging.2003.09.001","article-title":"Synaptic slaughter in Alzheimer's disease","volume":"24","author":"Coleman","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/01.WNL.0000140626.48118.0A","article-title":"A focus on the synapse for neuroprotection in Alzheimer disease and other dementias","volume":"63","author":"Coleman","year":"2004","journal-title":"Neurology"},{"issue":"4 Suppl.","key":"10.1016\/j.neurobiolaging.2006.06.021_bib34","first-page":"S1","article-title":"Consensus recommendations for the postmortem diagnosis of Alzheimer's disease","volume":"18","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0197-4580(98)00022-0","article-title":"Consensus report of the work group on: molecular and biochemical markers of Alzheimer's disease","volume":"19","year":"1998","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib36","first-page":"A276","article-title":"Braak & Braak staging and dementia in the oldest-old: preliminary results from the 90+ study","volume":"64","author":"Corrada","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib37","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib38","first-page":"A145","article-title":"Do patients enrolled in clinical trials for Alzheimer's disease (AD) actually have AD at autopsy?","volume":"64","author":"Corey-Bloom","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib39","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.287.18.2335","article-title":"Alzheimer disease","volume":"287","author":"Cummings","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00005072-199904000-00008","article-title":"Alzheimer neuropathologic alterations in aged cognitively normal subjects","volume":"58","author":"Davis","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1474-4422(06)70357-X","article-title":"Biomarkers for the early diagnosis of Alzheimer's disease","volume":"5","author":"De Leon","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib42","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/19083","article-title":"A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain","volume":"398","author":"De Strooper","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/neur.1996.0056","article-title":"Structural correlates of cognition in dementia: quantification and assessment of synaptic change","volume":"5","author":"DeKosky","year":"1996","journal-title":"Neurodegeneration"},{"issue":"Suppl. 2","key":"10.1016\/j.neurobiolaging.2006.06.021_bib45","first-page":"A60","article-title":"Human amyloid-imaging studies with Pittsburgh Compound-B in mild cognitive impairment (MCI): is MCI the critical period of amyloid plaque deposition?","volume":"66","author":"DeKosky","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005072-199704000-00001","article-title":"The pathogenesis of senile plaques","volume":"56","author":"Dickson","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncb960","article-title":"Reconstitution of gamma-secretase activity","volume":"5","author":"Edbauer","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib48","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archneur.57.6.808","article-title":"The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort","volume":"57","author":"Elias","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1172\/JCI200318162","article-title":"NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo","volume":"112","author":"Eriksen","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib50","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.262.18.2551","article-title":"Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported","volume":"262","author":"Evans","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib51","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta(42) in humans","author":"Fagan","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib52","first-page":"379","article-title":"Estimating the validity of the Clinical Dementia Rating Scale: the CERAD experience. Consortium to establish a registry for Alzheimer's disease","volume":"8","author":"Fillenbaum","year":"1996","journal-title":"Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000211873","article-title":"Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmabige Veranderung der Hirnrinde bei seniler Demenz","volume":"22","author":"Fischer","year":"1907","journal-title":"Monatsschr Psychiatr Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib54","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/brain\/121.9.1631","article-title":"Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study","volume":"121","author":"Fox","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib55","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00002512-199915050-00004","article-title":"Worldwide prevalence and incidence of dementia","volume":"15","author":"Fratiglioni","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib56","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1074\/jbc.271.17.10169","article-title":"Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells","volume":"271","author":"Frederikse","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib57","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archpsyc.55.9.809","article-title":"The relationship between age, sex, and the incidence of dementia and Alzheimer's disease","volume":"55","author":"Gao","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib58","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1212\/WNL.45.3.461","article-title":"The Consortium to establish a registry for Alzheimer's disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease","volume":"45","author":"Gearing","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib59","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease","volume":"60","author":"Giannakopoulos","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib60","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib61","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0079-6123(08)64022-4","article-title":"Neurofibrillary pathology of Alzheimer's disease and other tauopathies","volume":"117","author":"Goedert","year":"1998","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib62","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1074\/jbc.275.8.5535","article-title":"Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease","volume":"275","author":"Gong","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib63","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib64","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.mp.4001508","article-title":"Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy","volume":"9","author":"Gotz","year":"2004","journal-title":"Mol Psychol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1212\/WNL.54.1.105","article-title":"The Oregon Brain Aging Study: neuropathology accompanying healthy aging in the oldest old","volume":"54","author":"Green","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib66","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archneur.56.3.281","article-title":"Biomarkers of Alzheimer disease","volume":"56","author":"Growdon","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib68","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1212\/01.wnl.0000176053.98907.3f","article-title":"Dementia incidence may increase more slowly after age 90: results from the Bronx Aging Study","volume":"65","author":"Hall","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib69","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib70","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib72","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archneur.55.9.1185","article-title":"Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease","volume":"55","author":"Haroutunian","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib73","first-page":"125","article-title":"Tau protein in normal and Alzheimer's disease brain: an update","volume":"3","author":"Hartigan","year":"1998","journal-title":"Alzheimer Dis Rev"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib74","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jnnp.64.1.44","article-title":"Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine serine (L250S) substitution at codon 250 of the presenilin 1 gene","volume":"64","author":"Harvey","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib75","doi-asserted-by":"crossref","first-page":"36895","DOI":"10.1074\/jbc.M502861200","article-title":"A gamma-secretase-independent mechanism of signal transduction by the amyloid precursor protein","volume":"280","author":"Hass","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib76","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00005072-199906000-00008","article-title":"Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease","volume":"58","author":"Hatanpaa","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2 Suppl. 1","key":"10.1016\/j.neurobiolaging.2006.06.021_bib77","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00019442-199821001-00002","article-title":"Epidemiology of dementia and Alzheimer's disease","volume":"6","author":"Hendrie","year":"1998","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib78","first-page":"12","article-title":"Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice","author":"Heneka","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib79","first-page":"419","article-title":"Transgenic mouse models of Alzheimer's disease: phenotype and application","volume":"14","author":"Higgins","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib80","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.neuropharm.2005.07.004","article-title":"Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro","volume":"49","author":"Hirohata","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib81","first-page":"1075","article-title":"The neuropathological changes associated with normal brain aging","volume":"11","author":"Hof","year":"1996","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib82","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.neurobiolaging.2005.06.005","article-title":"Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample","volume":"27","author":"Ibach","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib83","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.expneurol.2004.06.011","article-title":"Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury","volume":"190","author":"Ikonomovic","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib84","series-title":"International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). DHHS Publication No. (PHS) 91-1260","year":"2005"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib85","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/WNL.45.5.957","article-title":"Neuropsychological detection and characterization of preclinical Alzheimer's disease","volume":"45","author":"Jacobs","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib86","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/jnen\/62.12.1220","article-title":"Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease","volume":"62","author":"Jankowsky","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib87","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1523\/JNEUROSCI.5080-04.2005","article-title":"Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease","volume":"25","author":"Jankowsky","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib88","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/01.WNL.0000042088.22694.E3","article-title":"Early onset familial Alzheimer's disease: mutation frequency in 31 families","volume":"60","author":"Janssen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib89","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0925-4439(00)00033-8","article-title":"Transgenic mouse models of Alzheimer's disease","volume":"1502","author":"Janus","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl. 1","key":"10.1016\/j.neurobiolaging.2006.06.021_bib90","first-page":"A275","article-title":"Alzheimer and Lewy body pathology in centenarian case series","volume":"6","author":"Jicha","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib91","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/WNL.51.3.728","article-title":"The incidence of dementia: a meta-analysis","volume":"51","author":"Jorm","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib92","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s004010050524","article-title":"Alzheimer-type pathology in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)","volume":"92","author":"Kaido","year":"1996","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib93","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.1976.00500040001001","article-title":"The prevalence and malignancy of Alzheimer's disease: a major killer","volume":"33","author":"Katzman","year":"1976","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib94","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ana.410230206","article-title":"Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques","volume":"23","author":"Katzman","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib95","doi-asserted-by":"crossref","first-page":"31746","DOI":"10.1074\/jbc.M503259200","article-title":"Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease","volume":"280","author":"Kelly","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib96","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0021-9150(94)90011-6","article-title":"Apolipoprotein E and B polymorphisms\u2014longevity factors assessed in nonagenarians","volume":"105","author":"Kervinen","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib97","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archneur.1985.04060100083029","article-title":"Diagnosis of Alzheimer's disease","volume":"42","author":"Khachaturian","year":"1985","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib98","first-page":"3","article-title":"A proposed strategy for international collaborative research in brain aging and Alzheimer's disease","volume":"10","author":"Khachaturian","year":"1990","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib99","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0197-4580(01)00350-5","article-title":"The challenges of developing and validating molecular and biochemical markers of Alzheimer's disease","volume":"23","author":"Khachaturian","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib100","doi-asserted-by":"crossref","first-page":"40288","DOI":"10.1074\/jbc.C100447200","article-title":"The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a Notch-like manner","volume":"276","author":"Kimberly","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib101","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0197-4580(01)00312-8","article-title":"ADDLs & protofibrils\u2014the missing links?","volume":"23","author":"Klein","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib102","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib103","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/jnen\/62.11.1087","article-title":"Neuropathology of cognitive normal elderly","volume":"62","author":"Knopman","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib104","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1601-183X.2005.00124.x","article-title":"Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease","volume":"4","author":"Kobayashi","year":"2005","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib105","series-title":"Psychiatrie. Ein Lehrbuch fur Studierende und Artze. II. Band, Klinische Psychiatrie","author":"Kraepelin","year":"1910"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib106","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1212\/WNL.40.9.1364","article-title":"The validity of three clinical diagnostic criteria for Alzheimer's disease","volume":"40","author":"Kukull","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib107","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","article-title":"A prospective study of Alzheimer disease in Down syndrome","volume":"46","author":"Lai","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib108","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib109","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cell.2005.01.015","article-title":"Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice","volume":"120","author":"Lazarov","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib110","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.278.16.1327","article-title":"A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia","volume":"278","author":"Le Bars","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib111","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib112","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","article-title":"Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation","volume":"3","author":"Lemere","year":"1996","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib113","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1523\/JNEUROSCI.3246-05.2005","article-title":"Amyloid plaques and amyloid-beta oligomers: an ongoing debate","volume":"25","author":"Lesne","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib114","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib115","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer's disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib116","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","article-title":"Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease","volume":"20","author":"Lim","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib117","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0197-4580(01)00299-8","article-title":"Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice","volume":"22","author":"Lim","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib118","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1523\/JNEUROSCI.4225-04.2005","article-title":"A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model","volume":"25","author":"Lim","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib119","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archneur.1995.00540290075020","article-title":"The \u2018preclinical phase\u2019 of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort","volume":"52","author":"Linn","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib120","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1002\/mds.10562","article-title":"Update on epidemiological aspects of progressive supranuclear palsy","volume":"18","author":"Litvan","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib121","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1212\/WNL.45.7.1323","article-title":"Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease","volume":"45","author":"Locke","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib122","first-page":"1959","article-title":"Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis","volume":"46","author":"Lopresti","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib123","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.ATV.14.7.1084","article-title":"Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians","volume":"14","author":"Louhija","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib124","first-page":"309","article-title":"The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes","volume":"78","author":"Lovestone","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib125","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1091230","article-title":"ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease","volume":"304","author":"Lustbader","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib126","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/BF00294177","article-title":"Senile plaques in temporal lobe epilepsy","volume":"87","author":"Mackenzie","year":"1994","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib127","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneur.60.9.1202","article-title":"Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42","volume":"60","author":"Maddalena","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0197-2456(01)00189-1","article-title":"Double placebo design in a prevention trial for Alzheimer's disease","volume":"23","author":"Martin","year":"2002","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib129","first-page":"2112","article-title":"Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons","volume":"45","author":"Masur","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib130","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1471-4159.2003.01654.x","article-title":"Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease","volume":"85","author":"Matsubara","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib131","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1056\/NEJM199802193380804","article-title":"Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease","volume":"338","author":"Mayeux","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib132","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/glia.440070114","article-title":"Microglia in degenerative neurological disease","volume":"7","author":"McGeer","year":"1993","journal-title":"Glia"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib133","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies","volume":"47","author":"McGeer","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib134","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/jnen\/63.10.1028","article-title":"Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of Alzheimer type","volume":"63","author":"McKeel","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib135","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib136","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000065889.42856.F2","article-title":"Influence of Alzheimer pathology on clinical diagnostic criteria in dementia with Lewy bodies","volume":"60","author":"Merdes","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib137","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1212\/WNL.58.2.209","article-title":"Incidence of AD may decline in the early 90s for men, later for women: The Cache County Study","volume":"58","author":"Miech","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib138","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib139","first-page":"132","article-title":"Making the diagnosis of Alzheimer's disease. A primer for practicing neurologists","volume":"117","author":"Mirra","year":"1993","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib140","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","article-title":"The Consortium to establish a registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease","volume":"39","author":"Morris","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib141","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archneur.63.1.15","article-title":"Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria","volume":"63","author":"Morris","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib142","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00005072-199902000-00008","article-title":"Neurons may live for decades with neurofibrillary tangles","volume":"58","author":"Morsch","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib143","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JAD-2005-8406","article-title":"Potential inflammatory biomarkers in Alzheimer's disease","volume":"8","author":"Mrak","year":"2005","journal-title":"J Alzheimer Dis"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib144","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1749-6632.1996.tb34405.x","article-title":"Neurotrophic and neuroprotective effects of hAPP in transgenic mice","volume":"777","author":"Mucke","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib145","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9440(10)64573-7","article-title":"Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease","volume":"157","author":"Mukaetova-Ladinski","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib146","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1212\/WNL.46.3.673","article-title":"Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham Study","volume":"46","author":"Myers","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib147","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/mp.56.3.132","article-title":"Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E","volume":"56","author":"Nathoo","year":"2003","journal-title":"Mol Pathol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib148","first-page":"21","article-title":"Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria","volume":"6","author":"Nagy","year":"1995","journal-title":"Dementia"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib149","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1474-4422(05)70223-4","article-title":"Frontotemporal dementia","volume":"4","author":"Neary","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(00)03589-3","article-title":"Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib151","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.57.8.967","article-title":"The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy","volume":"57","author":"Newman","year":"1994","journal-title":"J Neurolog Neurosurg Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib152","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1532-5415.1998.tb01076.x","article-title":"Absence of vascular dementia in an autopsy series from a dementia clinic","volume":"46","author":"Nolan","year":"1998","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl. 1","key":"10.1016\/j.neurobiolaging.2006.06.021_bib153","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000213357","article-title":"Accumulation of amyloid precursor protein and beta-protein immunoreactivities in axons injured by cerebral infarct","volume":"38","author":"Nukina","year":"1992","journal-title":"Gerontology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib154","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(99)00860-5","article-title":"Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians","volume":"277","author":"Panza","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib156","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3233\/JAD-2000-23-408","article-title":"Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor","volume":"2","author":"Passer","year":"2000","journal-title":"J Alzheimer Dis"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib157","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.neurobiolaging.2004.09.014","article-title":"Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models","volume":"26","author":"Patel","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib158","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1021\/jm0502541","article-title":"Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(\u2212)(42) secretion","volume":"48","author":"Peretto","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib159","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12031-002-0026-2","article-title":"Statin therapy for Alzheimer's disease: will it work?","volume":"19","author":"Petanceska","year":"2002","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib160","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jama.273.16.1274","article-title":"Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals","volume":"273","author":"Petersen","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib161","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib162","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib163","first-page":"A127","article-title":"Role of hippocampal volumes in predicting progression to mild cognitive impairment","volume":"64","author":"Petersen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib164","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1148\/radiol.2262011600","article-title":"Neuroimaging and early diagnosis of Alzheimer disease: a look to the future","volume":"226","author":"Petrella","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib165","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/WNL.56.12.1690","article-title":"Prevalence of Alzheimer's disease in very elderly people. A prospective neuropathological study","volume":"56","author":"Polvikoski","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib166","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000090252","article-title":"Incidence of dementia in very elderly individuals: A Clinical, Neuropathological and Molecular Genetic Study","volume":"26","author":"Polvikoski","year":"2005","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib167","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.58.9.1395","article-title":"Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease","volume":"58","author":"Price","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib168","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1212\/01.WNL.0000160107.02316.BF","article-title":"Incidence and etiology of dementia in a large elderly Italian population","volume":"64","author":"Ravaglia","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib169","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","article-title":"Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions","volume":"11","author":"Rebeck","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib170","first-page":"A144","article-title":"Intravenous immunoglobulin (IVIg) treatment causes dose-dependent alterations in \u03b2-amyloid (A\u03b2) levels and anti-A\u03b2 antiobody titers in plasma and cerebrospinal fluid (CSF) of Alzheimer's disease (AD) patients","volume":"64","author":"Relkin","year":"2005","journal-title":"Neurology"},{"issue":"suppl 2","key":"10.1016\/j.neurobiolaging.2006.06.021_bib171","first-page":"A66","article-title":"Amyloid imaging with Pittsburgh Compound-B (PIB) in AD, MCI, and highly intelligent older adults","volume":"66","author":"Rentz","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib172","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.45.1.51","article-title":"Nonsteroidal anti-inflammatory drugs in Alzheimer's disease","volume":"45","author":"Rich","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib173","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.410300310","article-title":"Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980\u20131990 prevalence findings","volume":"30","author":"Rocca","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib174","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00702-003-0025-7","article-title":"The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance","volume":"110","author":"Rockenstein","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib175","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jnnp.56.6.583","article-title":"Molecular pathology of Alzheimer's disease","volume":"56","author":"Rossor","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib176","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/neur.1996.0052","article-title":"Clinical features of sporadic and familial Alzheimer's disease","volume":"5","author":"Rossor","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib177","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib178","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1532-5415.2003.51072.x","article-title":"The \u201cAlzheimerization\u201d of dementia research","volume":"51","author":"Royall","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib179","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archneur.55.3.395","article-title":"A prospective study of cognitive function and onset of dementia in cognitively healthy elders","volume":"55","author":"Rubin","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib180","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1212\/01.wnl.0000188873.13444.85","article-title":"Prodromal cognitive signs of dementia in 85-year-olds using four sources of information","volume":"65","author":"Sacuiu","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib181","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"336","author":"Sano","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib182","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","article-title":"Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms","volume":"24","author":"Sastre","year":"2006","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib183","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1212\/01.WNL.0000147470.58328.50","article-title":"Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset","volume":"63","author":"Saxton","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib184","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng0194-29","article-title":"Genetic associations with human longevity at the APOE and ACE loci","volume":"6","author":"Schachter","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib185","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ana.410330209","article-title":"Synapse loss in the temporal lobe in Alzheimer's disease","volume":"33","author":"Scheff","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib186","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib187","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib188","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1212\/WNL.55.3.370","article-title":"\u201cPreclinical\u201d AD revisited: neuropathology of cognitively normal older adults","volume":"55","author":"Schmitt","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib189","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/30756","article-title":"Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain","volume":"393","author":"Schroeter","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev.cb.10.110194.002105","article-title":"Cell biology of the amyloid \u03b2-protein precursor and the mechanism of Alzheimer's disease","volume":"10","author":"Selkoe","year":"1994","journal-title":"Annu Rev Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib191","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","article-title":"Toward a comprehensive theory for Alzheimer's disease","volume":"924","author":"Selkoe","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib192","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","article-title":"Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases","volume":"6","author":"Selkoe","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib193","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib194","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","article-title":"Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease","volume":"10","author":"Shoghi-Jadid","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib195","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z","article-title":"Volume and number of neurons of the hippocampal formation in normal aging and Alzheimer's disease","volume":"379","author":"Simic","year":"1997","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib196","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/sleep\/26.7.893","article-title":"A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease","volume":"26","author":"Singer","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib197","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archneur.57.6.839","article-title":"The course of cognitive impairment in preclinical Alzheimer disease: 3- and 6-year follow-up of a population-based sample","volume":"57","author":"Small","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib198","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/01.WNL.0000133007.87028.09","article-title":"Worker functions and traits associated with occupations and the development of AD","volume":"63","author":"Smyth","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib199","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.275.7.528","article-title":"Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study","volume":"275","author":"Snowdon","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib200","doi-asserted-by":"crossref","first-page":"450","DOI":"10.7326\/0003-4819-139-5_Part_2-200309021-00014","article-title":"Healthy aging and dementia: findings from the nun study","volume":"139","author":"Snowdon","year":"2003","journal-title":"Ann Int Med"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib201","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.62.5.753","article-title":"Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results","volume":"62","author":"Sparks","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib202","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0014-4886(03)00399-6","article-title":"Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment","volume":"184","author":"Stackman","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib203","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequence of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib204","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1021\/bi035627j","article-title":"Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing","volume":"43","author":"Su","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib205","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopsych.2004.07.021","article-title":"Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele","volume":"56","author":"Sunderland","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib206","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1096\/fj.03-0961fje","article-title":"Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease","volume":"18","author":"Sung","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib207","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","article-title":"A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer's disease","volume":"63","author":"Swerdlow","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib208","first-page":"CD004031","article-title":"Ibuprofen for Alzheimer's disease","volume":"2","author":"Tabet","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib209","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib210","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1212\/WNL.50.1.283","article-title":"Prevalence of dementia over age 100","volume":"50","author":"Thomassen","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib211","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1212\/01.WNL.0000163773.21794.0B","article-title":"Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years","volume":"64","author":"Tierney","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib212","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1212\/WNL.55.9.1278","article-title":"The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease","volume":"55","author":"Tiraboschi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib213","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2990.1999.00182.x","article-title":"REVIEW: tau protein pathology in Alzheimer's disease and related disorders","volume":"25","author":"Tolnay","year":"1999","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib214","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.expneurol.2004.12.005","article-title":"Stereologic analysis of hippocampal Alzheimer's disease pathology in the oldest-old: evidence for sparing of the entorhinal cortex and CA1 field","volume":"193","author":"von Gunten","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib215","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1242\/jcs.01323","article-title":"The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor","volume":"117","author":"von Rotz","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib216","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1042\/BST20051087","article-title":"The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention","volume":"33","author":"Walsh","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib217","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.04-3182fje","article-title":"Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib218","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1523\/JNEUROSCI.4660-04.2005","article-title":"Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2","volume":"25","author":"Wang","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib219","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib220","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)92338-8","article-title":"Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease","volume":"344","author":"West","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib221","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.neurobiolaging.2003.12.005","article-title":"Hippocampal neurons in pre-clinical Alzheimer's disease","volume":"25","author":"West","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib222","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-1-24","article-title":"Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage","volume":"1","author":"Wilcock","year":"2004","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib223","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2014beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib224","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1749-6632.2000.tb06404.x","article-title":"Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders","volume":"903","author":"Xuereb","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib225","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","article-title":"Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease","volume":"23","author":"Yan","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib226","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib227","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0092-8674(95)90073-X","article-title":"Beta-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomoter activity","volume":"81","author":"Zheng","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2006.06.021_bib228","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","article-title":"Neurovascular mechanisms of Alzheimer's neurodegeneration","volume":"28","author":"Zlokovic","year":"2005","journal-title":"Trends Neurosci"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458006002351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458006002351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T13:22:07Z","timestamp":1555766527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458006002351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":228,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0197458006002351"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.06.021","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}